project id: TCGA-UVM; case submitter id: TCGA-VD-A8KD; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.32; rna integrity number: 7.9; age at index: 72; days to birth: -26457; days to death: 114; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1940; year of death: 2012; age at diagnosis: 26457; ajcc clinical m: M1; ajcc clinical n: N0; ajcc clinical stage: Stage IV; ajcc clinical t: T4a; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 603; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-VD-A8KD-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;